Skip to main content

Table 1 Patient characteristics

From: Accuracy of tumor segmentation from multi-parametric prostate MRI and 18F-choline PET/CT for focal prostate cancer therapy applications

Patient

Age (years)

PSA at time of biopsy (ng/mL)

Time interval between MRI and PET (days)

Time interval between imaging and biopsy (days)

Time interval from biopsy to prostatectomy (days)

Volume of Gleason ≥ 7 disease at pathology (mL)

Standard biopsy highest Gleason score

Targeted biopsy highest Gleason score

Final maximum Gleason score at prostatectomy

Number of additional Gleason 3+3 cancers at prostatectomy

1

57

4.6

0

23

63

0.19

3 + 3

3 + 4

3 + 4

4

2

73

4.3

0

21

61

1.35

3 + 4

Negative

3 + 4

6

3

73

4.6

0

15

133

1.35

3 + 3

3 + 4

3 + 4

2

4

60

23.0

19

6

55

3.15

3 + 4

4 + 4

4 + 3

1

5**

64

3.0

0

14

120

0.15

3 + 3

3 + 3

3 + 4

4

6

65

24.4

25

56

99

1.37

Negative

3 + 4

4 + 3

0

7

62

4.6

47

28

146

0.57

Negative

4 + 3

4 + 3

2

8

66

20.4

45

49

106

6.31

3 + 4

4 + 3

4 + 3

0

9

59

4.7

37

35

169

0.91

3 + 3

4 + 5

4 + 5

0

10

66

8.6

35

7

79

3.73

Negative

3 + 4

3 + 4

0

  1. **Excluded from analysis as lesion was not identified by readers